These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 21696910

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Laminitis and the equine metabolic syndrome.
    Johnson PJ, Wiedmeyer CE, LaCarrubba A, Ganjam VK, Messer NT.
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):239-55. PubMed ID: 20699172
    [Abstract] [Full Text] [Related]

  • 3. Lamellar pathology in horses with pituitary pars intermedia dysfunction.
    Karikoski NP, Patterson-Kane JC, Singer ER, McFarlane D, McGowan CM.
    Equine Vet J; 2016 Jul; 48(4):472-8. PubMed ID: 25869529
    [Abstract] [Full Text] [Related]

  • 4. Equine laminitis: what is all the hype about hyperinsulinaemic laminitis?
    Wylie CE.
    Vet J; 2013 May; 196(2):139-40. PubMed ID: 23168265
    [No Abstract] [Full Text] [Related]

  • 5. Field treatment and management of endocrinopathic laminitis in horses and ponies.
    Walsh DM.
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):379-90. PubMed ID: 20699182
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Endocrinopathic laminitis.
    McGowan CM.
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):233-7. PubMed ID: 20699171
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pathology of Natural Cases of Equine Endocrinopathic Laminitis Associated With Hyperinsulinemia.
    Karikoski NP, McGowan CM, Singer ER, Asplin KE, Tulamo RM, Patterson-Kane JC.
    Vet Pathol; 2015 Sep; 52(5):945-56. PubMed ID: 25232034
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Incidence and risk factors for recurrence of endocrinopathic laminitis in horses.
    de Laat MA, Reiche DB, Sillence MN, McGree JM.
    J Vet Intern Med; 2019 May; 33(3):1473-1482. PubMed ID: 30972832
    [Abstract] [Full Text] [Related]

  • 14. Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction.
    Horn R, Bamford NJ, Afonso T, Sutherland M, Buckerfield J, Tan RHH, Secombe CJ, Stewart AJ, Bertin FR.
    Equine Vet J; 2019 Jul; 51(4):440-445. PubMed ID: 30417404
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Continuous intravenous infusion of glucose induces endogenous hyperinsulinaemia and lamellar histopathology in Standardbred horses.
    de Laat MA, Sillence MN, McGowan CM, Pollitt CC.
    Vet J; 2012 Mar; 191(3):317-22. PubMed ID: 21873088
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Overview of current laminitis research.
    Eades SC.
    Vet Clin North Am Equine Pract; 2010 Apr; 26(1):51-63. PubMed ID: 20381735
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis.
    Donaldson MT, Jorgensen AJ, Beech J.
    J Am Vet Med Assoc; 2004 Apr 01; 224(7):1123-7. PubMed ID: 15074858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.